2020 COVID-19 Pharmacy Practice Considerations Series - Pharmacy Practice Considerations in the Setting of COVID-19
The educational series will provide resources and updated guidance for pharmacists and pharmacy technicians on the pharmacy practice considerations needed for the management of COVID-19 patients, including shortage mitigation, pharmacotherapy options, emergency preparedness, and medication safety.
Target Audience
Pharmacists - P
Pharmacists - T
Learning Objectives
Pharmacist-P and Pharmacist-T
Describe strategies for successfully mitigating COVID-19 related pharmacy challenges and issues as presented.
Pharmacist-P
Review the current evidence based COVID-19 guidelines.
Pharmacist-T
Discuss COVID-19 pharmacy practice considerations.
Additional Information
Attachment | Size |
---|---|
Helpful Tips for Users | 23.29 KB |
Information for CE | 127.23 KB |
Presentation | 1.32 MB |
Relevant financial relationships: Daniel Abazia will discuss off-label use of drugs - Azithromycin and Hydroxychloroquine for COVID-19 – and will discuss investigative use of drugs - Remdesevir for COVID-19. No other planning committee or presenter has anything to disclose.
Planning committee members
Jackie Stokes, BS
Manager, Pharmacy Program Services
Vizient
Gretchen Brummel
PharmD, BCPS
Pharmacy Executive Director
Vizient
Katrina Harper
PharmD, MBA, BCPS, BCSCP
Clinical Pharmacy Director
Vizient
Course reviewer
Katrina Harper
PharmD, MBA, BCPS, BCSCP
Clinical Pharmacy Director
Vizient
Presenters
Randy Gerwitz, RPh
Pharmacy Executive Director
Vizient
Gretchen Brummel, PharmD, BCPS
Pharmacy Executive Director
Vizient
Daniel Abazia, PharmD
Director of Pharmacy
Capital Health
Joint Accreditation Statement:
In support of improving patient care, Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Designation Statements:
PHARMACY
Vizient, Inc. designates this activity for a maximum of 1.00 ACPE credit hours.
Universal Activity Number: JA0006103-0000-20-083-L04-P - JA0006103-0000-20-083-L04-T
CEU
Vizient, Inc. will award CEUs to each participant who successfully completes this program. The CEU is a nationally recognized unit of measure for continuing education and training programs that meet certain criteria (1 contact hour = 0.1 CEU).
Available Credit
- 1.00 ACPE Pharmacist
- 1.00 ACPE Pharmacy Technician
- 1.00 General CE - Attendance